Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA's New Hypogonadism Guidance Focuses On Non-Testosterone Products

Jan 04 2018

• By Derrick Gingery

female scientist working with microscope

Related Content

Recent And Upcoming FDA Advisory Committee Meetings

Dec 29 2017

Mereo On The Move With Strong COPD Data And US Listing Plan

Dec 18 2017

Mereo BioPharma sets up shop with Novartis spin-offs

Jul 30 2015

Hypogonadism Trial Designs: FDA Panel Favors Symptom Assessments, Fertility Measures

Dec 07 2016

Repros Therapeutics Needs New Pivotal Trial For Low T Drug Enclomiphene

Dec 01 2015

Related Companies

Clarus Therapeutics Holdings, Inc.

Lipocine Inc.

Antares Pharma, Inc.

Mereo BioPharma Group plc

Novartis AG

Repros Therapeutics, Inc.

Additional Topics

United States Drug Approval Standards Regulation Gynecology & Urology

More from Approval Standards

More from Pathways & Standards

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window